PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
171 hedge funds and large institutions have $321M invested in PDL BioPharma, Inc. in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 72 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 72
Holders
171
Holding in Top 10
–
Calls
$476K
Puts
$188K
Top Buyers
| 1 | +$4.31M | |
| 2 | +$4.29M | |
| 3 | +$4.1M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$2.73M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$2.48M |
Top Sellers
| 1 | -$4.47M | |
| 2 | -$3.47M | |
| 3 | -$3.29M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.23M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$2.89M |